“immunotherapy” Archives

in
Entry Author Date Location
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity 06/06/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Want to Communicate Your Science? First, Step Back 04/19/17 San Francisco
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Houston Technology Center Chooses Banker, Civic Leader as New CEO 01/09/17 Texas
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap 09/09/16 National
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Page 1 of 5 next page »